In spite of ongoing campaigns against growing genetically
modified crops in East Africa, the effects of climate change, pests and
diseases as well as rapid population growth could see farmers in the region
embrace GM crops as soon as biotechnology laws are passed.
Scientists who gathered in Kampala on September 27 to
mark 10 years of the existence of the African Agricultural Technology
Foundation (AATF) said farmers in Uganda, Kenya,
Tanzania, Rwanda and Burundi must grow GM crops alongside their conventional
crops if the region is to achieve food security.
AATF is a not-for-profit organisation that promotes
public-private partnerships for access to and delivery of appropriate
agricultural technologies for sustainable use by smallholder farmers in
sub-Saharan Africa.
Yonah Baguma, a principal research officer at the
National Agricultural Research Organisation in Uganda said conventional crop
breeding has proven unsuccessful in making crops to diseases and pests.
“We as scientists embarked on using biotechnology in
developing resistant planting materials because conventional methods proved
futile,” said Dr Baguma.
Sterile crops
Dr Baguma added that some crops such as cassava and
bananas are difficult to breed for resistance using conventional methods as
they are sterile, and thus do not produce fruits.
So far, Uganda has approved and carried out field trials
on banana to test black sigatoka disease resistance (2007-2009); two
trials to evaluate Bacterium throngesis and roundup ready cotton
(2009-2010); a trial to test cassava mosaic virus resistance (2009-2010); and
two ongoing trials to test banana bio-fortified with vitamin A and iron, to
test resistance to banana bacterial wilt.
The scientists are also carrying out confined field
trials on GM maize to test their resistance to stem borer and drought as well
as Irish potato to test resistance to Phytophthora infestans, the fungus
that causes potato blight.
This puts Uganda at the helm of carrying out confined
field trials on GM crops in different parts of the country.
Kenya is carrying out confined field trials on cassava to
test for resistance against cassava mosaic virus, cotton for insect resistance
and maize to test drought and insect resistance. The country’s scientists are
also carrying out research on sweet potato for disease resistance as well as
bio-fortified sorghum enhanced with vitamin A, zinc and iron.
Commercialisation
Kenya is working towards commercialising GM cotton by
next year after successful field trials showed the crop’s ability to cushion
farmers against high production costs. Uganda projects to commercialise the
crop in 2017. Tanzania, Burundi and Rwanda are yet to start trials on GM crops.
The GM cotton variety is
resistant to pests and diseases, which have contributed to low yields.
In
Africa, only South Africa, Egypt, Burkina Faso and Sudan have commercialised GM
crops, according to the Global Status of Commercialised Biotech/GM Crops: 2012
report released by the International Service for the Acquisition of
Agri-Biotech Applications.
Until
2008, South Africa was the only country in Africa that allowed the commercial
cultivation of GM crops, such as maize, cotton and soybeans.
In
the same year, Egypt started growing small quantities of GM maize, followed by
Burkina Faso, which allowed GM cotton. Last year, Sudan allowed growing of GM
cotton.
South
Africa accounts for nearly all of the three million hectares of GM crop
plantings in Africa, dwarfing the 129,000 hectares in a largely GM-free Europe
but still a tiny fraction of the 170 million hectares of global GM crops.
Globally,
more land in developing countries is under GM crops compared with
industrialised countries, for the first time since the introduction of the
technology two decades ago, the report said.
“Out
of the 28 countries that planted GM crops in 2012, 20 were developing and eight
were industrial countries, compared with 19 developing and 10 industrial
countries in 2011,” said the report, signifying a major shift by farmers to
growing GM crops.
Many
African countries are currently at different stages of enacting biosafety
legislation, ranging from functional, interim and “work-in-progress” national
biosafety frameworks.
No comments:
Post a Comment